Skip to content

Non-invasive Assessment of Synaptic Plasticity

Non-invasive Assessment of Brain and Spinal Synaptic Plasticity in Patients Affected by Movement Disorders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05353517
Acronym
NEUROPLAST
Enrollment
50
Registered
2022-04-29
Start date
2022-12-01
Completion date
2023-12-31
Last updated
2023-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Movement Disorders, Parkinson Disease

Brief summary

The pathophysiological mechanisms underlying Movement Disorders, including Parkinson's disease, have been related to altered synaptic plasticity affecting several structures of the central nervous system. Although several previous neurophysiologic investigations have shown abnormal long-term potentiation and depression-like plasticity in M1, other regions crucially involved in motor planning and execution, including the spinal cord, have been studied less. Parkinson's disease arises from the progressive loss of dendritic spines followed by atrophy of specific cortical (i.e. M1) and subcortical structures (i.e. putamen). These structural changes are responsible for the main clinical features of PD such as bradykinesia and rigidity. The present research project aims to probe non-invasively the main pathophysiologic mechanisms underlying altered synaptic plasticity in M1 and spinal cord and their relationship in a cohort of patients with movement disorders, including Parkinson's disease. More in detail, the investigators will use specific methodologies able to induce plasticity, including the repetitive transcranial magnetic stimulation (TMS), concerning the M1 and the focal muscle vibration, regarding the spinal cord. The neuromodulation protocol will imply 2 separate sessions, randomly scheduled to take into account the effect of the symptomatic pharmacologic treatment. Furthermore, patients will be randomly assigned to sham or real non-invasive stimulation groups. Before and after the stimulation protocol, the investigators will collect specific clinical as well as neurophysiologic measures (i.e., thresholds) according to standardized procedures. In conclusion, the goal of the study is to investigate the abnormal plasticity in the M1 and spinal cord in patients affected by specific movement disorders, through non-invasive techniques.

Interventions

DEVICEDevice: focal muscle vibration and theta burst stimulation

non invasive techniques of neuromodulation for inducing plasticity in M1 and spinal cord

Sponsors

Neuromed IRCCS
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* clinical diagnosis of Parkinson's disease

Exclusion criteria

* psychiatric disorders, including severe congnitive loss and depression

Design outcomes

Primary

MeasureTime frameDescription
Analysis of neurophysiologic measuresbaselineRest motor threshold

Countries

Italy

Contacts

Primary ContactAntonio Suppa, MD, PhD
antonio.suppa@uniroma1.it3494940365
Backup ContactFrancesco Asci, MD
francesco.asci@uniroma1.it3488263444

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026